SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced it will present a trial-in-progress poster for the Phase 3 OPERA-02 trial at the 2025 San Antonio Breast Cancer Symposium (SABCS 2025) taking place December 9-12, 2025 in San Antonio, TX. The trial is evaluating palaze ...

Core Insights - Counterpart Health has released a whitepaper demonstrating how its Counterpart Assistant (CA) technology enhances value-based care in resource-constrained primary care settings, particularly in high Area Deprivation Index (ADI) neighborhoods [1][2] Group 1: Diagnosis and Early Detection - Patients from socioeconomically disadvantaged neighborhoods attributed to a CA primary care provider (PCP) showed significantly higher diagnosis rates for chronic diseases in their first year after enrollment, with increases of 75% for diabetes, 89% for chronic kidney disease (CKD), 89% for chronic heart failure (CHF), and 70% for chronic obstructive pulmonary disease (COPD) [3] - CKD and diabetes patients were diagnosed at earlier clinical stages, with CKD patients showing initial markers at Stage 2 on average, compared to Stage 3A, and diabetes patients having average A1C levels of 6.8% versus 7.1% in the comparison group [4] Group 2: Care Utilization and Outcomes - CA PCP attribution was linked to a significant reduction in acute care utilization, with all-cause inpatient hospitalizations decreasing by 7.6% to 21.2% and 30-day readmissions dropping by 11.5% to 20.8% across the four chronic diseases studied [5] - The whitepaper emphasizes that early detection allows for timely interventions, potentially altering disease trajectories in communities burdened by chronic diseases [6] Group 3: Technology and Infrastructure - The CA technology integrates AI-powered clinical insights into workflows, enabling clinicians to identify high-risk patients and intervene earlier without increasing administrative burdens, thus facilitating proactive care in resource-constrained practices [7] - Counterpart Health aims to extend its data-driven technology platform beyond Clover Health's Medicare Advantage plan to improve patient outcomes and reduce healthcare costs nationwide [8]

Fairchild Completes a Nevada Trinity with Acquisition of Advanced Stage Carlin Queen Project Figure 1 - Carlin Queen Project VANCOUVER, B.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- via IBN – Fairchild Gold Corp. (“Fairchild” or the “Company”) (TSXV: FAIR, Frankfurt: Y4Y, OTCID: FCHDF), is pleased to announce that it has entered into a Binding Purchase Agreement (“BPA”) dated October 30th , 2025, with a private arm’s length party, to acquire a 100% interest in the drill-ready Carlin Queen gold and silver prop ...

TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy Inc (Nasdaq: STRF/STRC/STRK/STRD/MSTR) ("Strategy†or the "Company†), the largest corporate holder of bitcoin and the world's first Bitcoin Treasury Company, today announces financial results for the three-month period ended September 30, 2025 (the third quarter of its 2025 fiscal year). "In the third quarter and into October, Strategy continued to strengthen its position as the world's leading Bitcoin Treasury Company. We increased our bitcoin hold. ...

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate at the following investor conferences: TD Cowen's Immunology & Inflammation Summit (Virtual) - fireside chat on Wednesday, November 12, 2025, at 11:30 a.m. ET 2025 Jefferies Global Healthcare Conf ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- FTAI Infrastructure Inc. (NASDAQ:FIP) (the “Company” or “FTAI Infrastructure”) today reported financial results for the third quarter 2025. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release. Business Highlights Reported $70.9 million of Adjusted EBITDA, up 54% from the second quarter of 2025.Closed the acquisition of the Wheeling & Lake Erie Railway into a voting trust on Augus ...

Core Viewpoint - Gaming and Leisure Properties, Inc. (GLPI) reported strong financial results for Q3 2025, with record revenue, AFFO, and Adjusted EBITDA, driven by a diversified tenant base and strategic acquisitions [6][19]. Financial Highlights - Total revenue for Q3 2025 was $397.6 million, a 3.2% increase from $385.3 million in Q3 2024 [2]. - Income from operations rose to $337.2 million from $271.4 million year-over-year [2]. - Net income increased to $248.5 million compared to $190.1 million in the previous year [2]. - Funds from Operations (FFO) reached $315.5 million, up from $250.6 million [2]. - Adjusted Funds From Operations (AFFO) grew to $282.0 million from $268.2 million [2]. - Adjusted EBITDA was $366.4 million, an increase from $346.4 million [2]. - The annualized dividend per share was $3.12, with a dividend yield of 6.69% [2]. Recent Developments - GLPI's lease coverages remain strong, with major tenants exhibiting rent coverage of over 1.8x [6]. - The company has committed significant funding for various projects, including $130 million for the relocation of Hollywood Casino Joliet and $225 million for Caesars Republic Sonoma County [9][10]. - GLPI acquired the real estate assets of Sunland Park Racetrack & Casino for $183.75 million, which is expected to be accretive to AFFO per share [11]. - The company is actively pursuing opportunities in tribal gaming and has established a unique funding agreement with the Ione Band of Miwok Indians [10]. Portfolio Update - As of September 30, 2025, GLPI's portfolio included interests in 68 gaming and related facilities across 20 states, with significant operators such as PENN and Caesars Entertainment [21].

Dallas, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- NL Industries, Inc. (NYSE: NL) today announced that its board of directors has declared a quarterly dividend of nine cents ($0.09) per share on its common stock, payable on December 16, 2025 to shareholders of record at the close of business on November 21, 2025. NL Industries, Inc. is engaged in the component products (security products and recreational marine components) and chemicals (TiO2) businesses. * * * * * Investor Relations Contact Bryan A. HanleyS ...

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced its operating results for the three and nine months ended September 30, 2025. “Overall, third quarter results were in line with our expectations. Our coastal and more urban markets maintained their strong performance while our sunbelt properties continued to experience tradeoffs between rate and occupancy,” commented President and Chief Executive Officer Christopher P. Marr. “We are encouraged as operating trends continue ...

DEFIANCE, Ohio, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SB Financial Group, Inc. (NASDAQ: SBFG) (“SB Financial” or the “Company”), a diversified financial services company providing full-service community banking, mortgage banking, wealth management, private client and title insurance services today reported earnings for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights compared to the third quarter of the prior year include: GAAP net income and Diluted Earnings per Share (“DEPS”) were $4. ...